# agilon health inc. (AGL) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Healthcare / Health Care Equipment & Supplies. Price $88.50, market value $1.5 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). agilon health inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 0.3×**. Each dollar of revenue is priced at 0.3×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 6.5×**. The shares trade at 6.5× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **Free-cash-flow yield: -5.7%** (5-yr avg -11.6%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Operating margin: -5.2%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -6.6%**. The company reported a net loss over the last twelve months.
- **Return on equity: -308.8%**. Return on equity is negative because earnings are negative.
- **Return on assets: -18.3%**. Each dollar of assets produces -18.3% of profit.

## Growth
- **Revenue growth (1 yr): -2.1%** (3-yr 35.4%/yr, 5-yr 37.2%/yr). Revenue fell 2.1% over the last year, against 37.2% a year compounded over five years: growth is slowing.

## Financial health
- **Debt to equity: 0.28**. Debt is 0.28 times equity: a conservative balance sheet.
- **Net debt / EBITDA: 0.5×**. It would take 0.5 years of operating earnings to repay net borrowings, within the comfortable range.
- **Altman Z-score: 4.38**. A Z-score of 4.38 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. agilon health inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: hold** (13 analysts). 13 analysts cover agilon health inc.; the consensus is hold, with an average price target of $115.08 (+30% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 192.6%** (YTD 413.8%, 3-mo -8.6%). The shares are up 192.6% over twelve months including dividends.
- **From 52-week high: -33.5%** (1083.2% above the low). Trading 33% below its 52-week high, deep in a drawdown.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 43**. An RSI of 43 is neutral.
- **Beta (1 yr): 2.66** (volatility 168%). Beta of 2.66 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=AGL · Page: https://foliofundamentals.com/stocks/agl

Not investment advice.